With semaglutide readily available from $88 every month and tirzepatide from $158 per month — both inclusive of clinician guidance, refills, and the total treatment suite — WellMedr's worth proposition is difficult to ignore in a very current market where GLP-1 treatment method expenses often run multiples larger through common healthcare chann